Female Subfertility: a Metabolic and Vascular Profile
Female Subfertility: a First Sign of Metabolic and Cardiovascular Anomalies?
1 other identifier
observational
512
1 country
1
Brief Summary
Introduction: Overall, 10 - 15% of couples seek specialist help once in their lives when a spontaneous pregnancy does not occur. These couples are defined subfertile when there is at least one year of unprotected intercourse without conceiving. Subfertility can have different causes which can be diagnosed with a basic fertility work-up. Unfortunately, the subfertility in 25% of the couples still remains unexplained. Hypothesis: The investigators hypothesize that cardio-metabolic and hemodynamic abnormalities reducing cardiovascular reserves relate to circulatory redistribution at the expense of uterine perfusion and with it women's fertility. This could especially be important in the subgroups with an unexplained subfertility and a decreased ovarian reserve. Interventions to improve these abnormalities could lead to better results in fertility treatment, better obstetric outcome and reduced lifelong health risks. Objective: The investigators want to examine specific cardio-metabolic and cardiovascular parameters in women of subfertile couples. The investigators want to evaluate the prevalence of metabolic syndrome in all women who are assessed for subfertility compared to healthy parous women. Furthermore in the women with an unexplained subfertility or with (signs of) a decreased ovarian reserve the cardiovascular profile will be studied consisting of the uterine artery pulsatility index (PI) as measure of uterine perfusion, the plasma volume as measure of venous reserve capacity, the intima media thickness of the carotid arteries as proxy of chronic strain and the endothelial function, measured by flow mediated dilatation (FMD) of the brachial artery. Study design: Cross-sectional Study population: The study group consists of subfertile women between 18 and 41 years who visit the fertility clinic in the Maastricht University Medical Centre with a primary or secondary subfertility. Women with an unexplained subfertility or with (signs of) a decreased ovarian reserve are evaluated for their cardiovascular profile. The control group consists of women with a history of an uneventful spontaneous pregnancy. Main study parameters:
- The uterine artery pulsatility index
- The plasma volume
- The intima media thickness (IMT)
- The endothelial function of the vascular system (FMD)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 30, 2014
CompletedFirst Posted
Study publicly available on registry
May 13, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedJanuary 7, 2016
January 1, 2016
2 years
April 30, 2014
January 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The prevalence of the metabolic syndrome in subfertile women
Subfertility is defined as trying to conceive for at least one year but did not lead to a pregnancy.
Within 3 months of start of a basic fertility work-up
The cardiovascular profile in subfertile women with an unexplained subfertility or a decreased ovarian reserve
The cardiovascular profile consists of the plasma volume as measure of venous reserve, the uterine artery pulsatility index as measure of uterine perfusion, the intima media thickness as proxy of chronic strain and the endothelial function of the vascular system.
Within 3 months after completing the basic fertility work-up
Study Arms (1)
Subfertile women
Women who visit the fertility clinic of the Maastricht University Medical Centre who start with a basic fertility work-up. Women diagnosed with an unexplained subfertility or with (signs of) a decreased ovarian reserve are asked for further participation in the study of the cardiovascular profile. As a control group parous women with an uncomplicated pregnancy more than 6 months ago will be asked for participation.
Eligibility Criteria
Study 1: * Study group: subfertile women between 18 and 41 years who visit our fertility clinic in the Maastricht University Medical Centre with a primary or secondary subfertility, independent of the cause of their subfertility * Control group: women with a history of an uneventful spontaneous pregnancy Study 2: Women who finished the basic fertility work up and are diagnosed with: * an unexplained subfertility: study group 1 * an "expected" decreased ovarian reserve: study group 2 Control group: women with a history of an uneventful spontaneous pregnancy Study 3: Women who received an IVF treatment in the period of 2010 - 2012 and: * study group: had a "proven" decreased ovarian response, defined as retrieving 3 oocytes or less at an ovum pick-up, despite maximal ovarian stimulation * control group: received and IVF/ICSI treatment because of a severe male subfertility
You may qualify if:
- Study 1
- Study group:
- primary subfertility, defined as having no previous pregnancy, or secondary subfertility, defined as a fertility problem after an ongoing pregnancy
- age 18 - 41 years
- Control group:
- women with an uneventful pregnancy in history
- at least 6 months post partum
- age 18 - 41 years
- Study 2
- Study groups:
- primary subfertility, defined as having no previous pregnancy, or secondary subfertility, defined as a fertility problem after an ongoing pregnancy
- age 18 - 41 years
- participation in study 1
- no abnormalities in the basic fertility work up ("unexplained subfertility"); study group 1, or "expected" decreased ovarian reserve (Follicle Stimulating Hormone (FSH) \> 8 u/l); study group 2
- Control group:
- +17 more criteria
You may not qualify if:
- Study 1
- current pregnancy
- hormonal medication
- breastfeeding
- Study 2
- hypertension, defined as a blood pressure exceeding 140 mm Hg systolic or 90 mm Hg diastolic, or the use of antihypertensive medication
- diabetes mellitus, defined as a fasting glucose level above 6,1 mmol/L or the use of antidiabetic medication
- hormonal medication
- current pregnancy
- breastfeeding
- Study 3
- extirpation of an ovary
- cystectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University Medical Centre
Maastricht, 6229 HX, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ron JT van Golde, MD, PhD
Maastricht University Medical Centre
- STUDY DIRECTOR
Marc E Spaanderman, Prof
Maastricht University Medical Centre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD candidate
Study Record Dates
First Submitted
April 30, 2014
First Posted
May 13, 2014
Study Start
April 1, 2014
Primary Completion
April 1, 2016
Study Completion
May 1, 2016
Last Updated
January 7, 2016
Record last verified: 2016-01